Fundraising Fox
Phinomics
11 employees on LinkedIn · 1 known investors
Find your way into Phinomics
1,486 people in our graph share verified history with the Phinomics team — schools, employers, funds. One of them is your warm intro.
Bryan Chambersunlockedknows Stephen Levene · together at University of Texas at Dallas (overlapped)
×2knows the team · via University of Texas at Dallas
×4knows the team · via UC San Diego
×5knows the team · via Creative Destruction Lab
Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.
Founders & leadership
SL
Stephen LeveneFounder, CTOStephen Levene holds a B.A. in Chemistry from Columbia University and a Ph.D. in Chemistry from Yale University, where his doctoral research focused on DNA bending and cyclization. He conducted postdoctoral research at UC San Diego on gel electrophoresis mechanisms and served as a Staff Scientist at Lawrence Berkeley National Laboratory's Human Genome Center, studying DNA topology, supercoiled DNA, and extrachromosomal circular DNA before founding Phinomics.
Investors · 1
Frequently asked questions
- What does Phinomics do?
- Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.
- Who founded Phinomics?
- Phinomics was founded by Massa Shoura, Stephen Levene.
- Who are Phinomics's investors?
- Phinomics's investors include Silicon Catalyst.